Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cohesion Technologies, Inc (CSON) -- Ignore unavailable to you. Want to Upgrade?

To: R. Gates who wrote (23)	8/1/1999 8:21:00 PM
From: R. Gates	Read Replies (1) \| Respond to of 28

Big potential gains ahead for those long on CSON... Big risk for those shorting this stock... Everything I'm telling you is public knowledge: But...IMO, Prepare to lose a lot of your net worth if you short this particular stock. CSON has 2 important trade shows coming up in the next month or so: European Society for Vascular Surgery September 2-5, 1999 Copenhagen, Denmark European Association for Cardio-Thoracic Surgery September 5-8, 1999 Glasgow, Scotland These are the first major European trade shows since they started marketing CoStasis in Europe. If you don't know it, CoStasis is CSON's first product and is quite revolutionary. Here's what it does... Cohesion's first product, CoStasis™, is a sprayable liquid hemostat for use in surgical procedures to control diffuse bleeding. This product is particularly useful in cardiovascular surgery, and also has potential applications in general, hepatic, orthopedic, and other surgical specialties. Cohesion received the CE mark for CoStasis in September 1998 and expects to launch CoStasis in Europe in early 1999. (They have already!) I have a STRONG feeling this product will be a hit at the above mentioned trade shows. So, short this stock if you want to, but do so at great risk to your net worth... R. Gates